• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本伯格氏病患者的现状。

Current status of patients with buerger disease in Japan.

作者信息

Hida Noriyuki, Ohta Takashi

机构信息

Department of Vascular Surgery, Aichi Medical University, Nagakute, Aichi, Japan.

出版信息

Ann Vasc Dis. 2013;6(3):617-23. doi: 10.3400/avd.oa.13-00012. Epub 2013 Aug 12.

DOI:10.3400/avd.oa.13-00012
PMID:24130618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3793184/
Abstract

THE PREVALENCE AND CLINICAL CHARACTERISTICS OF JAPANESE PATIENTS WITH BUERGER DISEASE (THROMBOANGIITIS OBLITERANS: TAO) were analyzed based on the Ministry of Health, Labour and Welfare (MHLW) database in 2009. A total of 129 new patients and 3639 patients in follow-up were selected according to the clinical criteria of TAO. The current number of patients with TAO in Japan is estimated at about 4000. The clinical course is relatively favorable, and the rates of limb morbidity and mortality were not completely discouraging.

摘要

基于2009年厚生劳动省(MHLW)数据库,对日本血栓闭塞性脉管炎(TAO)患者的患病率和临床特征进行了分析。根据TAO的临床标准,共选取了129例新患者和3639例随访患者。据估计,日本目前TAO患者数量约为4000人。临床病程相对良好,肢体发病和死亡率并非完全令人沮丧。

相似文献

1
Current status of patients with buerger disease in Japan.日本伯格氏病患者的现状。
Ann Vasc Dis. 2013;6(3):617-23. doi: 10.3400/avd.oa.13-00012. Epub 2013 Aug 12.
2
Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible.腔内治疗血栓闭塞性脉管炎(Buerger 病)所致肢体严重缺血:旁路手术不可行时的可行选择及其中期随访
AJR Am J Roentgenol. 2021 Feb;216(2):421-427. doi: 10.2214/AJR.20.23023. Epub 2020 Dec 16.
3
Buerger disease (thromboangiitis obliterans).血栓闭塞性脉管炎(伯格氏病)。
Tech Vasc Interv Radiol. 2014 Dec;17(4):234-40. doi: 10.1053/j.tvir.2014.11.003. Epub 2014 Nov 13.
4
Thromboangiitis obliterans: classic and new morphological features.血栓闭塞性脉管炎:经典与新的形态学特征
Virchows Arch. 2000 Jan;436(1):59-67. doi: 10.1007/pl00008199.
5
Reappraisal of thromboangiitis obliterans--a pathological contribution.血栓闭塞性脉管炎的重新评估——病理学方面的贡献
Verh Dtsch Ges Pathol. 2004;88:231-6.
6
[Thromboangiitis obliterans (Buerger disease) discovered by symptoms of arthralgia in a young woman].[一名年轻女性因关节痛症状发现血栓闭塞性脉管炎(伯格氏病)]
Praxis (Bern 1994). 1997 Dec 3;86(49):1945-8.
7
D-dimer levels in patients with thromboangiitis obliterans.血栓闭塞性脉管炎患者的D-二聚体水平。
Natl Med J India. 2019 May-Jun;32(3):134-136. doi: 10.4103/0970-258X.278685.
8
Thromboangiitis obliterans (Buerger's disease).血栓闭塞性脉管炎(伯格氏病)。
Vasa. 2014 Sep;43(5):337-46. doi: 10.1024/0301-1526/a000371.
9
Effectiveness of bosentan in the treatment of ischemic lesions in a case of thromboangiitis obliterans (Buerger disease): a case report.波生坦治疗血栓闭塞性脉管炎(伯格氏病)缺血性病变的疗效:一例报告
Dermatol Online J. 2011 Jul 15;17(7):4.
10
Antiphospholipid antibodies in thromboangiitis obliterans.血栓闭塞性脉管炎中的抗磷脂抗体。
Vasc Med. 2002;7(4):259-64. doi: 10.1191/1358863x02vm452oa.

引用本文的文献

1
Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans - Study Protocol for a Multicenter Prospective Interventional Trial.采用骨髓来源的单个核细胞植入治疗血栓闭塞性脉管炎所致严重肢体缺血的治疗性血管生成——一项多中心前瞻性干预试验的研究方案
Circ Rep. 2020 Sep 15;2(10):630-634. doi: 10.1253/circrep.CR-20-0086.
2
Three cases of dorsal metatarsal artery bypass in patients with Buerger disease.3例血栓闭塞性脉管炎患者的跖背动脉搭桥术
J Vasc Surg Cases Innov Tech. 2018 Aug 17;4(3):185-188. doi: 10.1016/j.jvscit.2018.03.011. eCollection 2018 Sep.
3
Buerger's disease: providing integrated care.血栓闭塞性脉管炎:提供综合护理。
J Multidiscip Healthc. 2016 Oct 12;9:511-518. doi: 10.2147/JMDH.S109985. eCollection 2016.
4
The Incidence and Prevalence of Thromboangiitis Obliterans in Taiwan: A Nationwide, Population-based Analysis of Data Collected from 2002 to 2011.台湾血栓闭塞性脉管炎的发病率和患病率:基于2002年至2011年全岛人口数据的分析
Clinics (Sao Paulo). 2016 Jul;71(7):399-403. doi: 10.6061/clinics/2016(07)08.

本文引用的文献

1
Buerger disease, smoking, and periodontitis.血栓闭塞性脉管炎、吸烟与牙周炎。
Ann Vasc Dis. 2008;1(2):80-4. doi: 10.3400/avd.AVDct00108. Epub 2008 Oct 24.
2
Buerger's disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran.布厄勒氏病作为不同社会经济发展的指标:伊朗东北部的一项横断面描述性研究。
Arch Med Sci. 2010 Jun 30;6(3):343-7. doi: 10.5114/aoms.2010.14253.
3
Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society.血管炎综合征管理指南(日本循环学会,2008年)
Circ J. 2011;75(2):474-503. doi: 10.1253/circj.cj-88-0007. Epub 2011 Jan 20.
4
Current pathological and clinical aspects of Buerger's disease in Japan.日本血栓闭塞性脉管炎的当前病理及临床状况
Ann Vasc Surg. 2006 Jan;20(1):148-56. doi: 10.1007/s10016-005-9436-2.
5
Oral bacteria in the occluded arteries of patients with Buerger disease.血栓闭塞性脉管炎患者闭塞动脉中的口腔细菌。
J Vasc Surg. 2005 Jul;42(1):107-15. doi: 10.1016/j.jvs.2005.03.016.
6
Clinical and social consequences of Buerger disease.血栓闭塞性脉管炎的临床及社会后果。
J Vasc Surg. 2004 Jan;39(1):176-80. doi: 10.1016/j.jvs.2003.08.006.
7
Current status of thromboangiitis obliterans (Buerger's disease) in Japan.日本血栓闭塞性脉管炎(伯格氏病)的现状。
Int J Cardiol. 2000 Aug 31;75 Suppl 1:S175-81. doi: 10.1016/s0167-5273(00)00190-x.
8
Factors affecting the long-term outcome of Buerger's disease (thromboangiitis obliterans).影响血栓闭塞性脉管炎(伯格氏病)长期预后的因素。
Int Angiol. 1999 Mar;18(1):58-64.
9
Decrease in prevalence of Buerger's disease in Japan.日本血栓闭塞性脉管炎患病率下降。
Surgery. 1998 Sep;124(3):498-502.
10
Buerger's disease: diagnosis and management.
Cardiovasc Surg. 1993 Jun;1(3):207-14.